The effects of acute and subchronic administration of dimethoate on γ-aminobutyric (GABA) concentration and receptor characteristics in rat cerebral cortices were investigated. After a single (acute exposure) or repeated administration of dimethoate, rat cerebral cortex was found to inhibit acetylcholinesterase (AChE) activity in a dosedependent manner. No significant alteration in the concentration of GABA or the numbers of GABA A receptor was noted in cortices of rats after acute exposure to dimethoate except the affinities of the receptor was found elevated significantly following the acute administration. But the GABA concentrations were significantly reduced in the 10 and 20 mg/kg groups after the subchronic dimethoate administration. No difference was found statistically in the GABA A receptor binding in cortices after the subchronic administration of dimethoate. But the K d values were significant decreased reflecting an elevated affinity of receptors in the three dimethoate groups as compared with that of control follow subchronic administration. It is suggested that the GABAergic system is involved in the intoxication of the dimethoate intoxication which is probably to counteract the enhanced cholinergic activity induced by dimethoate.
INTRODUCTION
The acute toxicity of organophosphorus compounds (OPs) are believed to be due primarily to the inhibition of acetylcholinesterase (AChE) resulting in an accumulation of acetylcholine (Ach) with a sustained overstimulation of Ach receptors in the clefts of central and peripheral neuronal synapses. 1) The discovery of some neurotransmitters including GABA, and its participation in a number of neurological and behavioral disorders suggest that other systems also may be influenced by organophosphates. 2, 3) The inhibitory amino acid (IAA) system, which has important physiologic and pathologic roles in anaesthesia and epilepsy, has been neglected in the exploration of mechanisms for OPs intoxication. It is well known that GABA is an important inhibitory neurotransmitter in the mammalian central nervous system (CNS). And evidence for neuronal coexistence of the GABAergic system including GABA, GABA A receptors, and its uptake system in some cholinergic neurons have been demonstrated in several previous anatomical investigations. [4] [5] [6] [7] [8] [9] [10] [11] It also has been demonstrated that Ach may regulate GABA synthesis. [12] [13] [14] Furthermore, other studies have demonstrated the interactions between cholinergic and GABAergic activities in the thalamus, neostriatum, striatum, and hippocampus involved in both physiologic and pathologic conditions. [15] [16] [17] [18] [19] On long-term exposure, some organophosphorus compounds, such as diisopropylfluorophosphate caused significant changes of GABA A receptor following 14 days of treatment. 20) The foregoing evidences indicate that the effects produced by organophosphates include a variety of behavioral and neurological manifestations, all of which can not be attributed to cholinergic hyperactivity solely. Other systems may, in addition or independently, be involved in OPs intoxicatin. 20, 21) Since the alterations of GABAergic system on OPs pesticides intoxication process remains obscured, more remedial approaches are needed to understand the GABAergic mechanisms involved in OPs intoxication. The present paper investigates the alterations of GABAergic system in rat cortex consequent to acute and subchronic dimethoate administration to explore the role of the IAA system in OPs poisoning. Ice-cold artificial cerebrospinal fluid (ACSF) contained NaCl 130 mmol/l, KCl 5 mmol/l, CaCl 2 2 mmol/l, MgSO 4 2 mmol/l, NaH 2 PO 4 1.25 mmol/l, NaHCO 3 26 mmol/l, glucose 10 mmol/l, and sucrose 10 mmol/l (pH 7.4). The stock solutions of GABA and DL-homoserine as internal standards were prepared at the concentration of 1 mM in filtered K 2 CO 3 solution (0.1 mol/l) containing 50% high-performance liquid chromatography (HPLC) grade methanol and stored at −20 • C for GABA determination. In the stock derivatizing solution, 13.4 mg of OPA was dissolved in 1 ml of dehydrated alcohol and 20 µl of 2-MCE was added. Then the solution was diluted with 4 ml of sodium tetraborate solution (0.1 mol/l, pH 9.6) and stored protected from light at 4 • C. The stock derivatizing solution can be used for one week by adding 20 µl of the 2-MCE daily to maintain the hydrosulfide concentration. All of the working solutions were freshly diluted from stock solutions. Animals --Male adult Sprague-Dawley rats (24 SD rats of 7 weeks old weighted 200 ± 20 g for acute administration; 24 SD rats of 6 weeks old weighted 160 ± 20 g for subchronic administration) were obtained from the Animal Research Center of Fudan University. All of the animals were randomly divided into four groups with 6 rats per group for both acute and subchronic treatments. The animals were conditioned in a temperature-controlled environment with a 12/12-hr light/dark cycle and allowed free access to water and food for 1 week before the experiment started. Animals were maintained in accordance with the principles stated in the Guidelines for the Care and Use of Laboratory Animals of the National Institutes of Health (U.S.A.) as well as Fudan University. Administration of Dimethoate --In the acute treatments, a single dimethoate dose of 38.9, 83.7, or 180.0 mg/kg was administered via oral gavage in volumes of 10 ml/kg. The treated rats were sacrificed by decapitation 8 hr after the treatment. In subchronic treatments, a dose of 5 (0.02 LD 50 ), 10 (0.08 LD 50 ), or 20 mg/kg (0.32 LD 50 ) was administered via oral gavage in volumes of 10 ml/kg body weight (bw) for 90 days except weekends. Both saline-treated control and dimethoate treated animals were sacrificed at the same time. Cortices from all of the animals were prepared for neurochemical determination and GABA A receptor binding assays. All animal experimental procedures were performed between 9 : 00 and 14 : 00 in the project. Observation of Animals --All animals were observed for overt neurobehavioral function status before and after acute and chronic dimethoate administrations. Specific signs according to OP poisoning, such as salivation, fasciculations, tremors, facial movements, head clonus, forelimb clonus, chewing, and straub tail were extensively observed and recorded. Determination of AChE Activity --The AChE activity was determined according to the procedure of Ellman's colorimetric method. 22) Briefly, a 30 µl of aliquot of homogenate was added to 3 ml phosphate buffer containing 5,5 -dithio-bis-nitrobenzoic acid (DTNB) and Thioacetyl-choline iodide (ASCh) and incubated in 37 • C water bath for 6 min, and then the activity was determined using a visible range spectrophotometer (Unico, Shanghai, China) at a wavelength of 412 nm. The AChE activity was expressed as micromoles of ASCh hydrolyzed by one gram of protein (µmol/g protein).
MATERIALS AND METHODS

Chemicals
Neurochemical Determinations --Following decapitation, the rat brains were quickly removed and the cerebral cortices were dissected above an ice box as quickly as possible. The samples were frozen in liquid nitrogen and stored at −80 • C until analysis. The cerebral cortices were homogenized with 8-10 strokes using a glass homogenizer in ice-cold ACSF (1 : 9, w/v). The homogenates were collected and centrifuged at 4 • C for 15 min at 3000 rpm for subsequent AChE activity, GABA concentrations and total protein assays. For the [ 3 H] GABA binding assays, the cerebral cortices were homogenized in ice-cold sucrose solution (0.32 mol/l, pH 7.4, 1 : 9, w/v) for synaptic membrane preparation. The homogenate was centrifuged at 1000 g for 10 min at 4 • C. The supernatant was collected and centrifuged for 20 min at 20000 g. The pellet was resuspended in 50 mM Tris-HCl buffer (pH 7.4) and centrifuged at 48000 g for 30 min. The last step was repeated once. The resulting pellet was frozen and stored at −70 • C for at least 18 hr before use. On the experiment day, membrane pellets were thawed at 4 • C and resuspended in 2 to 3 volumes (v/v) of Tris-HCl buffer containing 0.05% Triton X-100 before centrifugation at 48000 g for 30 min. The final pellet was then resuspended in Tris-HCl buffer to a final concentration of 200-350 µg/ml and used for next binding assays.
Determination of GABA Levels in the Cerebral
Cortices --After homogenization and centrifugation, the amino acids in prepared supernatants were derivatized in the working derivitizing solution containing OPA and 2-MCE under room temperature for 2 min. Then the GABA and internal standard were separated with a HP-1100 HPLC system and be detected at a fluorescence detector (Hewlett-Packard, Boeblingen, Germany) using isocratic elution as previously described. 23) A Hypersil octadecyl silica (ODS)-3 column (4.6 × 250 mm, 5 µm, GL, Kyoto, Japan) was used in the HPLC system. The mobile phase was potassium dihydrogen phosphate buffer (0.1 mol/l, pH 6.0) containing 30% methanol and 10% acetonitrile delivered at a flow rate of 1.0 ml/min which was filtered through a 0.2 µm nylon membrane and degassed by ultrasonification before use. DL-homoserine was served as the internal standard for further quantification. The detection limit was 0.01 µmol/l for GABA in the HPLC system with an inner-day variation of 3.44% and inter-day variation of 9.58%. [ 3 H] GABA Binding Assays --The binding assays were performed in duplicate in a final volume of 300 µl of buffer at room temperature for 45 min as described by Enna and Synder 24) with minor modifications of six increasing concentrations of [ 3 H] GABA ranging from 0.05 nM to 60 nM. Nonspecific binding was determined in the presence of 5 mM of unlabeled GABA. The incubation was terminated by rapid filtration through glass fiber filters pretreated with 0.15% polyethyleneimine for at least 2 hr to reduce filter binding. The radioactivity retained on the filters was counted with liquid scintillation spectrometry. Determination of Protein Concentration --The supernatant was collected after centrifugation at 3000 rpm and the total protein concentration was measured by the method of bicinchoninic acid kit according to the instructions of the manufacturer (Beyotime, Jiangsu, China) using bovine serum albumin as a standard. Data Analysis --AChE activity, GABA concentration, and densities and affinities of GABA A receptors are expressed as mean ± S.D. in the percentages of controls' values. For the binding assays, the B max (maximum binding capacity) and K d (equilibrium dissociation constant) values of GABA A receptor were determined by computerized Scatchard analysis with nonlinear regression (GraphPad Prism Program, version 4.0, San Diego, CA, U.S.A.). All other statistical analyses were performed with oneway analysis of variance (ANOVA) followed by Dunnett's post-hoc tests using SPSS (version 12) software and p < 0.05 between two means was considered significant statistically.
RESULTS
Effect of Dimethoate on the Gross Behavioral Activity and on AChE Activity
Acute administration of dimethoate in all doses induced typical signs of OPs-induced toxicity, which included weakness, salivation, fasciculations, tremor, facial movements, and head and forelimb clonus. Severe manifestations, such as unconsciousness, incontinence, and convulsions, were noted in rats from the dimethoate group 180 mg/kg bw. On chronic administration of dimethoate, only animals in 10 or 20 mg/kg doses exhibited some symptoms including salivation, secretion around eyes. No death occurred during both the acute and subchronic experimental period.
AChE activities were significantly reduced both after acute and subchronic treatments. Significant inhibition of AChE activity in the rat cerebral cortex was observed at all doses of dimethoate in a dosedependent manner in the acute assay (Fig. 1) . The percentages of AChE activities in the 38.9, 83.7, and 180.0 mg/kg bw groups were 43.0% (p < 0.05), 34.0% (p < 0.05), and 25.0% (p < 0.05) as com- pared with controls, respectively. And AChE activities were significantly reduced dose dependently after subchronic treatment of dimethoate too at the end of treatment (Fig. 2) . The percentages of the AChE activity values were reduced by 22.1% (p < 0.05), 37.2% (p < 0.05), and 57.9% (p < 0.05) of controls in the dimethoate 5.0, 10.0, and 20.0 mg/kg bw groups, respectively.
GABA Concentrations in Rat Cerebral Cortices Following Acute and Subchronic Administration of Dimethoate
GABA concentrations observed in the rat cerebral cortices after the acute and subchronic dimethoate administration were showed in Figs. 3 and 4, respectively. Following acute administration of dimethoate, the levels of GABA showed no significant changes in rat cerebral cortices as compared to the control group. The GABA concentrations were 95.87% (p > 0.05), 102.80% (p > 0.05), and 101.55% (p > 0.05) of control in three acute dimethoate-treated groups, respectively. For subchronic administration, the GABA concentration in the 5.0 mg/kg bw group represented a mild decrease but it did not reach significance statistically (89.08% of control, p > 0.05) compared with the control. However, the GABA concentrations were significantly reduced in the top two highest dosed groups after the subchronic dimethoate administration. The levels of the neurotransmitter were 41.33% (p < 0.05) and 37.44% (p < 0.05) of control in the dimethoate 10 and 20.0 mg/kg bw groups, respectively.
Effect of Dimethoate on GABA A Receptor Binding after Dimethoate Administration
Although a mild decrease of GABA A receptor binding in cortical synaptic membranes was observed in the treated groups as determined by Scatchard analysis, no difference was found statistically in the treated groups after the acute treatment with dimethoate. The numbers of binding sites were 97.79% (p > 0.05), 90.63% (p > 0.05), and 87.33% (p > 0.05) of control in the dimethoate 38.9, 83.7 mg/kg, and 180.0 mg/kg groups as compared to that of the control, respectively (Fig. 5) . Similarly, the B max value of the three dimethoate-treated groups also represented a slightly decrease as compared to the control while no significance was observed in all of them after subchronic administration of dimethoate (p > 0.05, Fig. 6 ).
Effects of Dimethoate Administration on the Affinities (K d ) of GABA A Receptors in Rat Cerebral Cortices
Eight hours following dimethoate administration, decrease in the K d values was observed without statistical significance (85.33% of control, p > 0.05) in the group of 38.9 mg/kg dimethoate in the cortical membranes as shown in Fig. 7 . But the percentages of the value were reduced significantly to 49.13% (p < 0.05) and 48.47% (p < 0.05) of control in the 83.7 and 180.0 mg/kg dimethoate groups, respectively. Subsequently, there were significant decreases in the three dimethoate groups with percentages of 63.90% (p < 0.05), 40.47% (p < 0.05), and 43.80% (p < 0.05) of controls for the K d values as compared with that of control after subchronic administration (Fig. 8) . 
DISCUSSION
Cholinergic mechanism plays a vital role in OPs-induced intoxication. The relationships between the cholinergic and amino acid neurotransmitter systems, especially the excitatory amino acid (EAA) system, have been implied by some experimental studies. 25, 26) But an imbalance between EAA and IAA systems is associated with many diseases. 27, 28) GABA is recognized as the principal inhibitory neurotransmitters in the cerebral cortex. 29) In the present study, we examined the alterations in GABA levels and GABA A receptors characteristics following acute and subchronic dimethoate administration to elucidate the noncholinergic mechanisms involved in OPs intoxication.
In the present study, the activities of AChE were reduced in a dose-dependent manner significantly following the acute dimethoate administration. While the GABA in rat cerebral cortices did not show statistical change in the three dosed groups compared to the control group after a single injection of dimethoate. But Shih and McDonough reported that GABA concentrations reached significantly high levels in the hippocampus, cortex and striatum after seizure onset following acute soman intoxication. 26) Similarly, remarkable increase in extracellular striatal levels of GABA concentrations was observed in rats with severe signs of poisoning after soman administration. 30) But these findings do not seem correlated well with our observations that the GABA neurotransmitter did not changed significantly after the acute dimethoate administration. It may be caused by the significant different toxicities of the two organophosphates. Dimethoate is a general use organophosphorus insecticide and be defined as a moderately toxic compound in U.S. Environmental Protection Agency (EPA) toxicity class II. While soman, one of the organophosphorus nerve agents used in chemical warfare, is exceedingly lethal to mammalian. In addition, no statistical significance of the numbers of GABA A receptor binding sites in cortices was observed after the acute dimethoate exposure too. However, the K d values were significantly reduced in the 83.7 and 180.0 mg/kg dimethoate groups as compared to that of control, that is, the affinities were elevated following the acute exposure to high dose of dimethoate. But Townsend reported that no significant alteration in GABA receptor affinity was noted in visual cortex of cats following an acute exposure to the organophosphorus compound diisopropylfluorophosphate. 31) This discordance probably results from the species and test substance differences in the two studies. The elevated affinities of GABA A receptors observed in the present study probably reflect an increased inhibitory response in an attempt to overcome the heightened neuronal excitation during the course of acute OPs intoxication.
Unlike the result after the acute dimethoate intoxication, the GABA concentration was reduced significantly in rat cortices both at the 10 and 20 mg/kg dimethoate groups treated subchronically. Prolonged exposure to dimethoate resulted in more noticeable alterations in GABA contents in rat cortices than acute intoxication. The decreased manifestation of GABA contents after long term dimethoate exposure can be explained in several possible ways: physiologically GABAergic system coexisted with cholinergic system in various brain regions of the rat. 7, 9-11) Both GABA and Ach can regulate each other's metabolism in many regions of rat brain. 18, 32) It might be believed the hyperactivity of the cholinergic system would recruit the modulation on the metabolism of the GABAergic system following long term OPs administration. GABA is formed by the decarboxylation of glutamate, a primary excitatory amino acid neurotransmitter in CNS, by glutamic acid decarboxylase in GABAergic terminals. The excitatory effect of the accumulated Ach in chronic dimethoate intoxication might reduce glutamate contents to prevent additional damage from excitotoxicity, which will decrease GABA synthesis subsequently. Another possible pathway is that the enhanced GABA recep-tor's affinity will probably reduce the synthesis of GABA in CNS compensaterily. Besides those, it also has the possibility that the GABA would be degrade or reuptake more efficiently after long term OPs exposure which would contribute to the decrease of GABA in the intoxication. But further precise mechanisms of GABA metabolism involved in dimethoate intoxication still need more investigation.
Furthermore, no significant alteration was noted in the numbers of GABA A receptor in rat cortices following the subchronic administration. However, the affinities significantly elevated by all three doses as compared to control after the subchronic exposure to dimethoate, which is similar with that of acute treatment with high doses of dimethoate in the study. On the basis of current findings, it can be hypothesized that an accumulation of Ach caused by OPs poisoning would induce the increase of the affinities of GABA A receptor in rat cortices following both acute and subchronic dimethoate exposure the increased GABA A receptor affinities will protect neurons from the hyperactivity of excessive Ach in the intoxication. Although dimethoate might act on GABA A receptor directly, it is still hard to define whether the decreased GABA A receptor K d values were induced by direct or indirect actions on the receptors by dimethoate currently. Further experiments are needed to elucidate this hypothesis with selective agonists or antagonists for each neurotransmitter system after dimethoate administration.
The results of our study suggested an involvement of GABAergic system in the intoxication of the organophosphate dimethoate besides the alteration in cholinergic system in the cortex of rats after acute and subchronic exposure to dimethoate. It indicated that the difference in the contents of GABA neurotransmitter in rat cerebral cortex after acute and subchronic administration of dimethoate. And an elevated affinity of GABA A receptor in rat cortex under subchronic exposure probably is to counteract the enhanced cholinergic activity induced by dimethoate.
